Work

Exploratory longitudinal analysis of cfDNA to reveal potential biomarkers of CRC progression and treatment response.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.4_suppl.207

Authors: Francesco Vallania, Karen Assayag, Hayley Warsinske, Peter Ulz, John St John, Carrie Brachmann, Scott D. Patterson, Dung Thai, Pankaj Bhargava, Manish A. Shah, Heinz-Josef Lenz, Johanna C. Bendell, Claudia Rubio

Institutions: Freenome (United States), Gilead Sciences (United States), NewYork–Presbyterian Hospital, Weill Cornell Medicine, University of Southern California, Sarah Cannon, Tennessee Oncology

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3005080935

Cites:

Cited by: 1

Related to: 10